Профилактическая медицина и здоровье · Oct 3, 2026

Artificial intelligence in menopause management: a review of modern tools and prospects for clinical application

By Бакоева Н, Бакоева Н, Baqoyeva N

This review systematizes four major areas of artificial intelligence (AI) application in menopause medicine: (1) risk prediction and patient stratification (osteoporosis, cardiovascular disorders, and cognitive impairment); (2) conversational AI systems and large language model (LLM)-based chatbots for patient counseling and education; (3) wearable devices and digital biomarkers for the objective assessment of vasomotor and other symptoms; and (4) clinical decision support systems for selecting menopausal hormone therapy (MHT). Particular attention is given to the methodological limitations of existing studies, issues of validation and model interpretability, data bias, and ethical and regulatory barriers to implementing AI in routine clinical practice. It is concluded that, given the current level of evidence, AI tools should be used as an adjunct to, rather than a substitute for, clinical decision-making, provided that they undergo prospective validation in representative populations, including non-Western populations.

doi.org/10.47689/2181-3663-vol5-iss5-pp61-69Open accessInterventions

AgingResearch.News